Associated Papers
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors.
Singh S et al.
Nature, 2025
40836083 (PubMed )
Supplement: 41586_2025_9433_MOESM4_ESM.zip › 2024-07-15654B-s4 › Table_S5_052925.xlsx › Tab_10-zscore_CCNA2_C_T
Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4.
Ognibene M et al.
International Journal of Molecular Sciences, 2022
35742955 (PubMed )
Supplement: ijms-23-06513-s001.zip › ijms-1748841-supplementary.pdf
Select a paper to view details